Market Cap

Nanexa AB Market Capitalization:

kr176.4 Million

SEK as of Jan. 1, 2024

US$17.5 Million

business Nanexa AB Company Profile

Nanexa AB Main Stock Listing

OMX: NANEXA

Market Capitalization History of Nanexa AB

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $89.09 B
MERCK Kommanditgesellschaft auf Aktien $67.64 B
Takeda Pharmaceutical Company Limited $47.71 B
Haleon plc $38.90 B
PPD, Inc. $16.58 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Nanexa AB market cap

Date Market Cap YoY Change
Jan. 1, 2024 kr176.4 M -8.93%
Jan. 1, 2023 kr193.7 M -2.37%
Jan. 1, 2022 kr198.4 M -63.16%
Jan. 1, 2021 kr538.6 M -3.40%
Jan. 1, 2020 kr557.6 M 50.42%
Jan. 1, 2019 kr370.7 M 7.27%
Jan. 1, 2018 kr345.5 M -25.05%
Jan. 1, 2017 kr461.0 M -9.82%
Jan. 1, 2016 kr511.2 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Nanexa AB Categories

Sweden languages Healthcare languages Drug Manufacturers—Specialty & Generic
Sweden Healthcare Sweden Drug Manufacturers—Specialty & Generic

Stocks & Indices

Nanexa AB has the following listings and related stock indices.


Stock: OMX: NANEXA

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.